Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Notices 3049 

HUD-subsidized housing that has either 

been rehabilitated in a green (e.g., case) 

or a traditional manner (e.g., control) 

from study sites across the United 

States. Pregnant women and children 

with asthma (ages 7–12 years) will 

donate blood samples (for assessment of 

allergy) and urine samples (for 

assessment of pesticide and VOC 

exposures). The children with asthma 

(ages 7–12 years) will be also tested for 

lung function and lung inflammatory 

markers. Questionnaires regarding home 

characteristics and respiratory 

symptoms will be administered at 3- 

month intervals over a 2-year period. Of 

the pregnant women enrolled, 

neurodevelopment of their infant will 

be tested at ages 1 week and 6 months. 

Environmental sampling of the air and 

dust in the participants’ homes will be 

conducted over a 2 year period (once in 

the home before rehabilitation, and then 

at four time points after rehabilitation 

has been completed: Baseline, 6 months, 

12 months, and 24 months). 

Environmental sampling includes 

measurements of air exchange rate, 

pesticides, VOCs, indoor allergens, 

fungi, temperature, humidity, and 

particulate matter. 

There is no cost to respondents other 

than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Forms Number of 

respondents 

Number of 

responses per 

respondent 

Average burden 

per response 

(in hours) 

Total burden 

(in hours) 

Mothers of enrolled 

children.

Screening questionnaire ............................ 800 1 5/60 067 

Baseline Questionnaire (Home Characteristics).688 1 15/60 172 

Baseline Questionnaire (for Mother) ......... 688 1 15/60 172 

Baseline Questionnaire (for Children 0–6 

years).

688 1 15/60 172 

Baseline Questionnaire (for Children 7–12 

with asthma).

688 1 15/60 172 

3, 9, 15, and 18-month Phone contact ..... 688 4 5/60 229 

6, 12, and 24-month Follow-up Questionnaire (for environment).688 3 10/60 344 

6, 12, and 24-month Follow-up Questionnaire (for women).688 3 10/60 344 

6, 12, and 24-month Follow-up Questionnaire (for children 0–6).688 3 10/60 344 

6, 12, and 24-month Follow-up Questionnaire (for asthmatic child 7–12).688 3 10/60 344 

Pregnant women ..... Screening questionnaire ............................ 800 1 5/60 67 

Baseline Questionnaire (Home Characteristics).688 1 15/60 172 

Baseline Questionnaire (for Pregnant 

woman).

688 1 15/60 172 

3, 9, 15, and 18-month Phone contact ..... 688 4 5/60 229 

6, 12, and 24-month Follow-up Questionnaire (for environment).688 3 10/60 344 

6, 12, and 24-month Follow-up Questionnaire (for women).688 3 10/60 344 

Post-delivery questionnaire ....................... 688 1 5/60 57 

Total .......................................................................................................................................................................................... 3745 

Dated: January 8, 2009. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E9–890 Filed 1–15–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Member 

Conflict Review, Program 

Announcement (PA) 07–318 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 1 p.m.–3 p.m., March 5, 

2009 (Closed). 

Place: National Institute for Occupational 

Safety and Health (NIOSH), CDC, 1095 

Willowdale Road, Morgantown, West 

Virginia 26506, telephone: (304) 285–6143. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the review, discussion, and 

evaluation of ‘‘Member Conflict Review, PA 

07–318.’’ 

Contact Person for More Information: Chris 

Langub, PhD, Scientific Review Official, 

NIOSH, CDC, 2400 Century Center, Atlanta, 

GA 30333, telephone: (404) 498–2543. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

mstockstill on PROD1PC66 with NOTICES

3050 Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Notices 

Dated: January 9, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–870 Filed 1–15–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Centers for 

Agricultural Disease and Injury 

Research, Education and Prevention, 

Program Announcement Number, 

PAR06–057 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 

7 p.m.–5 p.m., February 25, 2009 (Closed). 

7 p.m.–5 p.m., February 26, 2009 (Closed). 

7 p.m.–5 p.m., February 27, 2009 (Closed). 

Place: Courtyard Greenville, 2225 

Stantonsburg Road, Greenville, North 

Carolina 27834, telephone: (252) 329–2900. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the review, discussion, and 

evaluation of applications received in 

response to ‘‘Centers for Agricultural Disease 

and Injury Research, Education and 

Prevention, PAR06–057.’’ 

Contact Person for More Information: 

Stephen Olenchock, PhD, Scientific Review 

Administrator, 1095 Willowdale Road, 

Morgantown, West Virginia 26505, 

telephone: (304) 285–6271. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: January 8, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–873 Filed 1–15–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Centers for 

Agricultural Disease and Injury 

Research, Education and Prevention, 

Program Announcement Number, 

PAR06–057 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 

7 p.m.–5 p.m., February 10, 2009 (Closed). 

7 p.m.–5 p.m., February 11, 2009 (Closed). 

7 p.m.–5 p.m., February 12, 2009 (Closed). 

Place: Renaissance Columbus, 50 North 

3rd Street, Columbus, Ohio 43215, telephone: 

(614) 228–5050. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the review, discussion, and 

evaluation of applications received in 

response to ‘‘Centers for Agricultural Disease 

and Injury Research, Education and 

Prevention, PAR06–057.’’ 

Contact Person for More Information: 

Stephen Olenchock, PhD, Scientific Review 

Administrator, 1095 Willowdale Road, 

Morgantown, West Virginia 26505, 

telephone: (304) 285–6271. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: January 8, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–874 Filed 1–15–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Safety and Occupational Health Study 

Section (SOHSS), National Institute for 

Occupational Safety and Health 

(NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following Meeting of the 

aforementioned committee: 

Times and Dates: 

8 a.m.–5 p.m., February 17, 2009. 

8 a.m.–5 p.m., February 18, 2009. 

Place: Embassy Suites Hotel, 1900 

Diagonal Road, Alexandria, Virginia 22314, 

telephone (703)684–5900, fax (703) 684– 

1403. 

Status: 

Closed 8 a.m.–5 p.m., February 17, 2009. 

Closed 8 a.m.–5 p.m., February 18, 2009. 

Purpose: The Safety and Occupational 

Health Study Section will review, discuss, 

and evaluate grant application(s) received in 

response to the Institute’s standard grants 

review and funding cycles pertaining to 

research issues in occupational safety and 

health, and allied areas. 

It is the intent of NIOSH to support broadbased research endeavors in keeping with the 

Institute’s program goals. This will lead to 

improved understanding and appreciation for 

the magnitude of the aggregate health burden 

associated with occupational injuries and 

illnesses, as well as to support more focused 

research projects, which will lead to 

improvements in the delivery of occupational 

safety and health services, and the 

prevention of work-related injury and illness. 

It is anticipated that research funded will 

promote these program goals. 

Matters To Be Discussed: The meeting will 

convene to address matters related to the 

conduct of Study Section business and for 

the study section to consider safety and 

occupational health-related grant 

applications. 

These portions of the meeting will be 

closed to the public in accordance with 

provisions set forth in Section 552b(c)(4) and 

(6), Title 5 U.S.C., and the Determination of 

the Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention, pursuant to Section 10(d) 

Pub. L. 92–463. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: Price 

Connor, PhD, NIOSH Health Scientist, 1600 

Clifton Road, NE., Mailstop E–20, Atlanta, 

Georgia 30333, telephone (404) 498–2511, fax 

(404)498–2571. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: January 9, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–872 Filed 1–15–09; 8:45 am] 

BILLING CODE 4163–18–P 

mstockstill on PROD1PC66 with NOTICES